Hematoporphyrin Monomethyl Ether Photodynamic Therapy of Port Wine Stain: Narrative Review
- PMID: 37139084
- PMCID: PMC10150768
- DOI: 10.2147/CCID.S401447
Hematoporphyrin Monomethyl Ether Photodynamic Therapy of Port Wine Stain: Narrative Review
Abstract
Port wine stain (PWS) is a congenital and progressive capillary malformation characterized by structural abnormalities of intradermal capillaries and postcapillary venules. The visible manifestation is often considered a disfigurement and the accompanying social stigma often causes serious emotional and physical impact. Hematoporphyrin monomethyl ether (HMME) is a newly authorized photosensitizer for treating PWS in China. Hematoporphyrin monomethyl ether photodynamic therapy (HMME-PDT) has successfully treated thousands of Chinese patients with PWS since 2017, and HMME-PDT may be one of the most promising strategies for the treatment of PWS. However, there are few reviews published about the clinical use of HMME-PDT. So in this article, we want to briefly review the mechanism, efficacy evaluation, effectiveness and influencing factors, and the common postoperative reactions and treatment suggestions of HMME-PDT in the treatment of PWS.
Keywords: HMME; PDT; photodynamic therapy; photosensitizer; port wine stain.
© 2023 Diao et al.
Conflict of interest statement
The authors report no conflicts of interest in this work.
References
-
- Lei YKQ, Deng X. Epidemiological study of capillary malformation among 7299 infants under 1 year of age in China. J Eur Acad Dermatol Venereol. 2022;37:1–6. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
